Andere Kunden interessierten sich auch für
![Drugs between Research and Regulations]( "Drugs between Research and Regulations")
Drugs between Research and Regulations75,99 €![Statistics Applied to Clinical Trials]( "Statistics Applied to Clinical Trials")
Statistics Applied to Clinical Trials85,99 €![Drugs Affecting Lipid Metabolism VIII]( "Drugs Affecting Lipid Metabolism VIII")
Drugs Affecting Lipid Metabolism VIII77,99 €![Drug Research and Drug Development in the 21st Century]( "Drug Research and Drug Development in the 21st Century")
Drug Research and Drug Development in the 21st Century77,99 €![Clinical Pharmacology: Current Topics and Case Studies]( "Clinical Pharmacology: Current Topics and Case Studies")
Clinical Pharmacology: Current Topics and Case Studies110,99 €![The Challenge of CMC Regulatory Compliance for Biopharmaceuticals]( "The Challenge of CMC Regulatory Compliance for Biopharmaceuticals")
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals154,99 €![Pharmaceutical Suspensions]( "Pharmaceutical Suspensions")
Pharmaceutical Suspensions110,99 €
- Alpha-Adrenergic Blockers
- Alpha2-Adrenergic Agonists
- Angiotensin-Converting Enzyme Inhibitors
- Angiotensin II Receptor Blockers
- Antiarrhythmic Agents
- Antithrombotic Therapy
- Beta-Adrenergic Blockers
- Calcium Antagonists
- Diuretics
- Isotropic and asopressor Agents
- Lipid-Lowering Drugs
- Neuronal and Ganglionic Blockers
- Vasodilators.
This fourth edition of Current Cardiovascular Drugs is designed to provide an updated practical compendium of current knowledge regarding cardiovascular drug therapy in a concise, easily readable format. The book is organized into chapters by drug class, and details the pharmacologic characteristics of specific treatment entities. The clinical efficacy and limitations of the various drug therapies are discussed using supportive reference material from the most authoritative sources and published clinical trials.
- Alpha2-Adrenergic Agonists
- Angiotensin-Converting Enzyme Inhibitors
- Angiotensin II Receptor Blockers
- Antiarrhythmic Agents
- Antithrombotic Therapy
- Beta-Adrenergic Blockers
- Calcium Antagonists
- Diuretics
- Isotropic and asopressor Agents
- Lipid-Lowering Drugs
- Neuronal and Ganglionic Blockers
- Vasodilators.
This fourth edition of Current Cardiovascular Drugs is designed to provide an updated practical compendium of current knowledge regarding cardiovascular drug therapy in a concise, easily readable format. The book is organized into chapters by drug class, and details the pharmacologic characteristics of specific treatment entities. The clinical efficacy and limitations of the various drug therapies are discussed using supportive reference material from the most authoritative sources and published clinical trials.